Target intelligence / Profile preview

Transmembrane protein 201 (TMEM201)

Target
TMEM201
Molecular classification
Inner nuclear membrane protein, Transmembrane protein, Other
01

Overview

Transmembrane protein 201 (TMEM201), also known as NET5, SAMP1, or Ima1, is a conserved inner nuclear membrane protein characterized by five transmembrane segments. In human cells, TMEM201 localizes predominantly to the inner nuclear membrane, where it interacts with the linker of nucleoskeleton and cytoskeleton (LINC) complex via its N-terminus and other nuclear envelope components such as Lamin A/C and SUN2. TMEM201 modulates nuclear-cytoskeletal interactions, cell motility, centrosome positioning, and chromatin organization. It is essential for endothelial cell migration and angiogenesis in both in vitro and in vivo models, and its deficiency results in impaired vessel formation and reduced cell movement. Aberrant expression of TMEM201 has been implicated in tumor progression, highlighting its potential as a marker related to cancer cell migration. TMEM201 is not a classical drug target, but its functional role in cell migration and nuclear architecture makes it of emerging interest in the study of vascular biology and tumor metastasis.

Other names
NET5SAMP1RP13-15M17.2Ima1spindle-associated membrane protein 1spindle associated membrane protein 1
02

Biological functions

Regulation of endothelial cell migrationAngiogenesisNuclear envelope organizationBinding to actin filaments and laminsCentrosome tethering and spindle assemblyChromatin organization
03

Disease associations

Cancer (particularly breast cancer cell migration and tumor progression)Other (potential role in developmental vascular disorders, not directly linked to classical disease categories yet)

Beyond the preview

Go deeper on Transmembrane protein 201 (TMEM201).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 201 (TMEM201).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call